# Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

> **NCT00418145** · PHASE3 · TERMINATED · sponsor: **Fred Lublin** · enrollment: 16 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** megadose oral methylprednisolone
- **DRUG:** IV methylprednisolone

## Key facts

- **NCT ID:** NCT00418145
- **Lead sponsor:** Fred Lublin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-09
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** low enrollment - data was not analyzed for this study
- **Last updated:** 2017-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418145, "Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00418145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*